European Commission grants marketing authorisation for NEZGLYAL, first pharmacological treatment for cALD

Singapore, Sept. 28 -- Neuraxpharm Group and Minoryx Therapeutics have announced that the European Commission has granted marketing authorisation under exceptional circumstances for NEZGLYAL(R) (lerig... Read More

Deep Origin deploys AI-powered ADMET models across drug discovery programmes

Singapore, Sept. 28 -- Deep Origin and partners in the Pharmacological Research and Evaluation through Digital Integration and Clinical Trials Simulation (PREDICTS) consortium announced that their new... Read More

APEC's Opportunity to Lead: Transforming Lung Cancer Outcomes Across Asia Pacific

Singapore, Sept. 28 -- As Asia Pacific economies grapple with ageing populations, shrinking workforces and rising healthcare expenditure, they are also at the center of the global fight against lung c... Read More

Germfree expands executive leadership as it enters next phase of growth

Singapore, Sept. 28 -- Germfree, a full-lifecycle engineering and manufacturing partner for mission-critical environments across life sciences, healthcare and biocontainment, has announced the appoint... Read More

Novotech buys Agilex Biolabs in Australia

Singapore, Sept. 25 -- Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agreement with a wholly owned subsidiary of leading Australia... Read More

Qiagen launches QIAmini to automate small-batch sample preparation

Singapore, Sept. 25 -- QIAGEN N.V. has announced the launch of QIAmini, a compact automated sample preparation system designed to give research laboratories a time-saving and cost-efficient alternativ... Read More

Korea's Seoul National University Hospital joins hands with Cellares for automated manufacturing of Gene-Modified HSPC therapy

Singapore, Sept. 25 -- Cellares, US-based Integrated Development and Manufacturing Organisation (IDMO), and Seoul National University Hospital (SNUH), a leading translational medical centre in South K... Read More

Novo Nordisk receives Singapore approval for Wegovy(R) as first treatment for MASH with liver fibrosis

Singapore, Sept. 24 -- Novo Nordisk has announced that Singapore's Health Sciences Authority (HSA) has approved Wegovy(R) (once-weekly injectable semaglutide 2.4 mg) as the first approved treatment in... Read More

NUS Enterprise evolves into NUSX to expand global pathways for deep tech ventures

Singapore, Sept. 24 -- NUS Enterprise, the entrepreneurial heart of the National University of Singapore, has unveiled its next chapter as NUSX. The new identity reflects its evolution into an integr... Read More

Mayo Clinic Laboratories invests in Pathology Asia Holdings and LifeStrands Genomics to expand precision medicine in APAC

Singapore, Sept. 24 -- Mayo Clinic Laboratories and Pathology Asia Holdings have announced a strategic investment and collaboration aimed at expanding access to advanced diagnostics and precision medi... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»